25-Hydroxyvitamin D therapy in children with active juvenile rheumatoid arthritis: short-term effects on serum osteocalcin levels and bone mineral density.
Reed
A
A
Division of Rheumatology/Immunology, Northwestern University, Chicago, Ill.
Haugen
M
M
Pachman
L M
LM
Langman
C B
CB
D015652:25-Hydroxyvitamin D 2 / Q000627:therapeutic use*; D000293:Adolescent; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D015519:Bone Density / Q000187:drug effects*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D015675:Osteocalcin / Q000097:blood*; D010281:Parathyroid Hormone / Q000097:blood
D010281:Parathyroid Hormone; D015675:Osteocalcin; D015652:25-Hydroxyvitamin D 2